Given the data that lower levels of c-FLIPL may facilitate the growth of ECM-detached cancer cells, we hypothesized that low levels of c-FLIPL may be associated with poor clinical outcomes owing to tumor cell dissemination. This evidence concerns the gene CFLAR and neoplasm.